HSTI High Sierra Technologies, Inc.
Blank Checks · OTC · SEC CIK 1365388 · Fiscal year ends 12/31
Financial factors as of 2023-09-30 (2023Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-54.7%
TTM EPS YoY50.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-447.0%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets1,250.1%
Debt / equity—
Current ratio0.03x
Interest coverage-4.56x
Cash quality & payout
Operating cash flow / net income0.46x
Accruals ratio-242.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 | FY20192019-12-31 | FY20172017-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | — | $0 | $0 | $0 |
| SG&A expense | $181,971 | $220,576 | $222,561 | $200,030 | $22,119 |
| Operating income | -$238,364 | -$255,926 | -$257,911 | — | — |
| Interest expense | $66,473 | $58,359 | $42,955 | $13,029 | — |
| Pretax income | -$323,952 | -$316,437 | -$305,511 | -$476,247 | -$46,074 |
| Income tax | — | — | $0 | $0 | $0 |
| Net income | -$323,952 | -$316,437 | -$305,511 | -$476,247 | -$46,074 |
| EBITDA | -$181,971 | -$220,576 | -$222,561 | — | — |
| EPS (basic) | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| EPS (diluted) | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 |
| Weighted avg. shares (diluted) | 20.51M | 20.37M | 20.22M | — | — |
| Balance sheet | |||||
| Cash & equivalents | $12,258 | $55,351 | $41,770 | $5,207 | $32 |
| Current assets | $24,116 | $58,062 | $41,770 | $5,207 | $32 |
| PP&E, net | $77,386 | $90,345 | $125,695 | $161,045 | — |
| Total assets | $101,502 | $148,407 | $167,465 | $166,252 | $32 |
| Current liabilities | $561,785 | $484,672 | $469,893 | $447,670 | $429,971 |
| Total liabilities | $611,785 | $584,672 | $519,893 | $447,670 | $429,971 |
| Shareholders' equity | -$510,283 | -$436,265 | -$352,428 | -$281,418 | -$429,939 |
| Shares outstanding | 20.62M | 20.46M | 20.30M | 20.19M | 1.72M |
| Cash flow statement | |||||
| Operating cash flow | -$219,659 | -$176,519 | -$187,687 | -$422,853 | -$10,544 |
| Capital expenditure | $43,435 | — | $0 | $176,750 | — |
| Free cash flow | -$263,094 | — | -$187,687 | -$599,603 | — |
| Investing cash flow | -$43,435 | — | $0 | -$176,750 | $0 |
| Financing cash flow | $220,000 | $190,100 | $224,250 | $384,557 | $10,576 |
| Depreciation & amortization | $56,393 | $35,350 | $35,350 | $15,705 | — |
Free plan shows the latest 5 periods; Pro shows all 25 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.